68 results
8-K
EX-1.1
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Other Events
5:24pm
Materials. There has been no storage, generation, transportation, use, handling, treatment, Release or threat of Release of Hazardous Materials … be expected to have a Material Adverse Effect. “Hazardous Materials” means any material, chemical, substance, waste, pollutant, contaminant, compound
S-3ASR
CRNX
Crinetics Pharmaceuticals Inc
21 Jun 24
Automatic shelf registration
4:45pm
to any particular debt securities, preferred stock or warrants will be described in the applicable prospectus supplement or other offering materials
DEFA14A
CRNX
Crinetics Pharmaceuticals Inc
25 Apr 24
Additional proxy soliciting materials
4:48pm
Materials
Soliciting Material under §240.14a-12
Crinetics Pharmaceuticals, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s … with preliminary materials
Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11
Crinetics Pharmaceuticals C/O
D
uuvvgq0b6nw40p
11 Mar 24
$350.00 mm in equity, sold $350.00 mm, 36 investors
4:15pm
8-K
EX-10.1
9vljhwf
1 Mar 24
Crinetics Pharmaceuticals Announces Oversubscribed $350 Million Private Placement
4:07pm
8-K
EX-3.1
48x9l0t8sp f3ab
12 Dec 23
Amendments to Articles of Incorporation or Bylaws
4:35pm
8-K
EX-1.1
sgp9dhafn1zp
13 Sep 23
Crinetics Pharmaceuticals Announces Proposed Public Offering of Common Stock
5:23pm
DEFA14A
svrm1cbgu3pnk198js
27 Apr 23
Additional proxy soliciting materials
4:56pm